// App-Quantinova.ai

Sa1629 : Gastrointestinal Safety & Device Longevity of Long-Term PEG-J Used for Continuous Infusion of Levodopa-Carbidopa Intestinal Gel

Researchers

Presenter

  • David A. Johnson

Principal Investigators

  • Robert Hawes

  • Nathan Schmulewitz

  • Arvydas Vanagunas

  • Rod Gossen

  • Weining Z. Robieson

  • Susan Eaton

  • Jordan Dubow

  • Janet Benesh

Medical Centers

  • Northwestern University, Feinberg School of Medicine, Chicago, IL

  • University of Central Florida College of Medicine, Orlando, FL

  • OptumInsight, Saint Laurent, QC, Canada

  • University of Cincinnati, Cincinnati, OH

  • Eastern Virginia Medical School, Norfolk, VA

  • Digestive Disorders Associates, Annapolis, MD

Locations

  • United States

  • Canada

Companies

  • AbbVie Inc.

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Parkinson's disease

  • Peritonitis

Biomarkers

  • N/A

Drug/Treatment

  • Carbidopa and Levodopa

Outcome

  • N/A

Study Design

  • pharmacodynamics

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved